Figure 3
From: NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer
UALCAN analysis of NTN4 promoter methylation in breast cancer. NTN4 promoter methylation levels in breast cancer were compared based on different (A) sample types, (B) molecular subtypes (TNBC), (C) individual cancer stages, (D) lymph nodal status.
